Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Orthofix launches natural physiologic amniotic wound covering

Orthofix International, a developer of repair and regenerative products, has launched a natural physiologic wound covering for use in both spinal and orthopedic applications.

The wound covering VersaShield, which is processed from placental tissue by The Musculoskeletal Transplant Foundation (MTF), is an amniotic allograft tissue recovered from living donors during healthy child births.

Musculoskeletal Transplant Foundation CEO Bruce Stroever said for more than a century, doctors have used amniotic tissue for various clinical applications in general surgery, dental, Ob/Gyn, ocular surgery, spine and sports medicine.

"This is due to the beneficial anti-inflammatory, anti-adhesive, anti-microbial, and non-immunogenic properties of the tissue graft," Stroever added.

"MTF is pleased to continue our partnership with Orthofix on the introduction of VersaShield amniotic membrane in order to make innovative biologic solutions available to all spine and orthopedic surgeons."

Orthofix president and chief executive officer Robert Vaters said the company is excited to display its second biologic tissue form from MTF this week at the 2012 North American Spine Society meeting.

"This launch further demonstrates our commitment to expand our biologic offering, which goes hand in hand with our Value Proposition of providing surgeons a breadth of hardware, biologic, and stimulation solutions," Vaters added.